Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R)
Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. It has the potential for chronic obstructive pulmonary disease (COPD), asthama treatment. MW :145.5 KD
Supplier | Selleck Chemicals |
---|---|
Product # | A2443 |
Sku # | A2443-1mg*25 |
Pricing | 1mg*25, $2970.00 |